Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPL | P40238 | 7/20 | 0.57 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CTRC | Q99895 | 1/20 | 0.44 |
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.44 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.42 |
| ▸ | MMP14 | P50281 | 1/20 | 0.42 |
| ▸ | CASP6 | P55212 | 1/20 | 0.42 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.42 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.42 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4810070 | 0.98 | MPL (0.58) | MPLLDHACYP2D6CTRCHKDC1 | |
| SCHEMBL11507947 | 0.83 | MPL (0.58) | MPLLDHACYP2D6CTRCHKDC1 | |
| SCHEMBL27999180 | 0.82 | MPL (0.49) | MPLCYP2D6CTRCNSD2MMP14 | |
| SCHEMBL13851155 | 0.82 | MPL (0.53) | MPLLDHACYP2D6HKDC1TRPM4 | |
| SCHEMBL29575461 | 0.82 | MPL (0.53) | MPLLDHACYP2D6HKDC1TRPM4 | |
| SCHEMBL10033898 | 0.81 | MPL (0.60) | MPLLDHACTRCHKDC1TRPM4 | |
| SCHEMBL27566003 | 0.79 | CDK2 (0.53) | MPLLDHACYP2D6HKDC1CDK2 | |
| Ammonia Solution, Strong SCHEMBL25197168 | 0.79 | MPL (0.58) | MPLLDHACTRCHKDC1TRPM4 | |
| SCHEMBL5246088 | 0.79 | AURKB (0.53) | MPLCYP2D6CTRCCDK2NSD2 | |
| SCHEMBL11414363 | 0.79 | MPL (0.67) | MPLLDHACTRCHKDC1NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | S.C. JOHNSON & SON, INC. | 2002-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | ACHE, DDT, GAP43 | MPL 4856/4885LDHA 1723/4885CYP2D6 1331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.